Antibody Therapeutics for Life

Notices

Dr. Lawrence Cher is presenting Tanibirumab phase IIa interim data at THE 10TH COGNO ANNUAL SCIENTIFIC MEETINGS (COOPERATIVE TRAILS GROUP FRO NEURO-ONCOLOGY) on Monday 23rd -Tuesday 24th October 2017.
  • Written by Admin
  • Written date 2019-01-14 11:30:02
  • Inquire 1128
Dr. Lawrence Cher is presenting Tanibirumab phase IIa interim data at THE 10TH COGNO ANNUAL SCIENTIFIC MEETINGS (COOPERATIVE TRAILS GROUP FRO NEURO-ONCOLOGY) on Monday 23rd -Tuesday 24th October 2017, Rydges Melbourne Hotel, 186 Exhibition Street, Melbourne, VIC Australia.
List





Prev Dr. Jin-San Yoo, CEO of PharmAbcine is attending to THE 10TH COGNO ANNUAL SCIENT...
Next PharmAbcine is sponsoring THE 10TH COGNO ANNUAL SCIENTIFIC MEETINGS (COOPERATIVE...